A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/2011
11/10/2011	WO2011139710A1 Nucleic acid compounds with conformationally restricted monomers and uses thereof
11/10/2011	WO2011139391A1 Growth hormone receptor deficiency causes a major reduction in pro-aging signaling, cancer and diabetes in humans
11/10/2011	WO2011139295A1 Small molecule inhibitors of protein kinases
11/10/2011	WO2011139172A1 Diterpene compounds with antineoplastic activities and pharmaceutical compositions comprising same
11/10/2011	WO2011138975A1 High density poly-alkylene glycol-coated iron oxide gold core-shell nanoparticle
11/10/2011	WO2011138956A1 Novel prenylarene compound and use thereof
11/10/2011	WO2011138665A1 Novel immunomodulator and anti inflammatory compounds
11/10/2011	WO2011138565A1 Pharmaceutical combination containing lipoic acid, hydroxycitric acid and a somatostatin as active ingredients
11/10/2011	WO2011138557A2 Use of an anti-cd71 antibody for preparing a medicament
11/10/2011	WO2011138460A1 Progesterone receptor antagonists and uses thereof
11/10/2011	WO2011138409A1 Combretastatin analogs for use in the treatment of cancer
11/10/2011	WO2011138392A1 Compositions and methods of use for therapeutic low density lipoprotein -related protein 6 (lrp6) antibodies
11/10/2011	WO2011138391A1 Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies
11/10/2011	WO2011138334A1 Use of an extract obtained from plants of the family canellaceae in the treatment of cancer
11/10/2011	WO2011138307A1 Pyrrolo [3, 2 -d] pyrimidin-3 -yl derivatives used as activators of ampk
11/10/2011	WO2011138279A1 Novel antibody to a carbonic anhydrase
11/10/2011	WO2011137925A1 New pro-drugs of amaryllidaceae isocarbostyril products and their use against brain tumors
11/10/2011	WO2011137687A1 Antibody against carcinoembryonic antigen and uses thereof
11/10/2011	WO2011137528A1 Methods and compounds for inhibiting glycosyltransferases
11/10/2011	WO2011137516A1 Flavonoid dimers and their use
11/10/2011	WO2011113819A3 Diagnosis and treatment of cancer based on avl9
11/10/2011	WO2011112599A3 Immunogenic pote peptides and methods of use
11/10/2011	WO2011088137A3 Bad pathway gene signature
11/10/2011	WO2011087222A3 Anticancer peptide sequence
11/10/2011	WO2011084571A3 Azide derivatives for phototherapy
11/10/2011	WO2011082269A3 Substituted benzo-pyrimido-tetrazolo-diazepine compounds
11/10/2011	WO2011082245A3 Metalloenzyme inhibitor compounds
11/10/2011	WO2011081970A3 MOLECULES RELATED hERG Ion CHANNELS AND THE USE THEREOF
11/10/2011	WO2011081430A3 Polymer nanoparticle injection formulation composition containing rapamycin with improved water solubility, preparation method thereof, and anticancer composition for combined use with radiotherapy
11/10/2011	WO2011081408A3 Imatinib dichloroacetate and anti-cancer agent comprising the same
11/10/2011	WO2011081373A3 Method for preparing highly pure anhydrous crystalline docetaxel
11/10/2011	WO2011074903A3 Pharmaceutical composition containing a3 adenosine receptor agonist
11/10/2011	WO2011068386A3 Anticancer composition containing a kampheride compound as an active ingredient
11/10/2011	WO2011066390A3 Nanoscale adjuvants and related pharmaceutical compositions and methods
11/10/2011	WO2011066369A9 Antagonists of il-6 to raise albumin and/or lower crp
11/10/2011	WO2011026898A3 Drug activation system
11/10/2011	WO2011015958A3 Oncology therapies employing radioactive seeds
11/10/2011	WO2010078294A8 Method of preparing (+)-1,4-dihydro-7-[(3s,4s)-3methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
11/10/2011	US20110275810 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors
11/10/2011	US20110275708 Polycyclic compounds and methods related thereto
11/10/2011	US20110275707 Substituted afpo (6-aryl-4h-furo[3,2-c]pyran-4-one) derivatives as anti-cancer agents
11/10/2011	US20110275705 Stable injectable oil-in-water docetaxel nanoemulsion
11/10/2011	US20110275704 Stable Formulations for Lyophilizing Therapeutic Particles
11/10/2011	US20110275702 Novel DNA Nanostructures that Promote Cell-Cell Interaction and Use Thereof
11/10/2011	US20110275698 "test and treat" strategy for treating transforming hpv infection
11/10/2011	US20110275697 Regulation of cyclin d
11/10/2011	US20110275696 Thioxanthone-Based Autophagy Inhibitor Therapies to Treat Cancer
11/10/2011	US20110275690 New crystal form of sunitinib malate
11/10/2011	US20110275689 Preparation of 3-Pyrrole Substituted 2-Indolinone Derivatives
11/10/2011	US20110275686 Nanoparticle carrier systems based on poly(dl-lactic-co-glycolic acid) (plga) for photodynamic therapy (pdt)
11/10/2011	US20110275674 Small Molecules Modulator of Epigenetic Regulation and Their Therapeutic Applications
11/10/2011	US20110275673 Inhibitors of sphingosine kinase 1
11/10/2011	US20110275672 Methods for treating cancers using polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
11/10/2011	US20110275671 Dihydroindolinone derivatives
11/10/2011	US20110275669 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
11/10/2011	US20110275656 3H-Imidazo [4, 5-C] Pyridine- 6 -Carboxamides As Anti-Inflammatory Agents
11/10/2011	US20110275655 Pyrimidinecarboxamide derivatives as inhibitors of syk kinase
11/10/2011	US20110275653 Heterocyclic compounds and their uses
11/10/2011	US20110275651 Fused ring heteroaryl kinase inhibitors
11/10/2011	US20110275650 Methods and compositions related to targeting monoacylglycerol lipase
11/10/2011	US20110275648 Flurbiprofen analogs and methods of use in treating cancer
11/10/2011	US20110275646 Novel Compounds for Treatment of Cancer and Disorders Associated with Angiogenesis Function
11/10/2011	US20110275645 Small Molecules for Inhibition of Protein Kinases
11/10/2011	US20110275644 Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
11/10/2011	US20110275643 Aroylquinoline compounds
11/10/2011	US20110275641 Preventives or remedies for Alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound
11/10/2011	US20110275640 Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound
11/10/2011	US20110275639 C5aR ANTAGONISTS
11/10/2011	US20110275635 Small molecule inhibitors of nads, namnat, and nmnat
11/10/2011	US20110275633 2,4-diaminopyrimidine derivates as ptk2- inhibitors for the treatment of abnormal cell growth
11/10/2011	US20110275631 Heteroaryl Substituted Indole Compounds Useful as MMP-13 Inhibitors
11/10/2011	US20110275629 Pyridazino-pyridinone Compounds and Methods of Use
11/10/2011	US20110275627 Indolizine inhibitors of leukotriene production
11/10/2011	US20110275625 Heteroaryl Diamide Compounds Useful as MMP-13 Inhibitors
11/10/2011	US20110275615 Novel substituted amides, their preparation and use
11/10/2011	US20110275611 Chemical compounds
11/10/2011	US20110275607 Nuclear transport modulators and uses thereof
11/10/2011	US20110275606 Substituted porphyrins
11/10/2011	US20110275604 Aminoalkylsterol compounds with antitumoral and neuroprotective activity
11/10/2011	US20110275603 Novel immunomodulator and anti-inflammatory compounds
11/10/2011	US20110275600 Methods for increasing endogenous plasmalogen levels
11/10/2011	US20110275597 Pharmaceutical composition
11/10/2011	US20110275596 Methods for treating neoplasia and for identifying compositions useful in such therapy
11/10/2011	US20110275590 Conjugates for cancer therapy and diagnosis
11/10/2011	US20110275589 3,5-DISUBSTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO[4,5-d]PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF
11/10/2011	US20110275588 Fused Diimidazodiazepine Compounds and Methods of Use and Manufacture Thereof
11/10/2011	US20110275587 Topical delivery of viscous medications for the treatment of diseases associated with chronic sinusitis
11/10/2011	US20110275585 Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells
11/10/2011	US20110275581 Nuclear export inhibitors of topoisomerase ii alpha
11/10/2011	US20110275577 Methods of treating dermatologic, gynecologic, and genital disorders with caffeic acid analogs
11/10/2011	US20110275576 Carbohydrate-Cyclopamine Conjugates as Anticancer Agents
11/10/2011	US20110275575 Peptide inhibitors of protein kinase c
11/10/2011	US20110275574 Method of inhibiting proliferation of hepatic stellate cells
11/10/2011	US20110275569 Proteases targeting agents
11/10/2011	US20110275554 Compounds
11/10/2011	US20110274738 Functionalized chemically inert polymers for coatings
11/10/2011	US20110274725 Decomposable biocompatible hydrogels and system and method for using same
11/10/2011	US20110274723 Cancer immunotherapy and method of treatment
11/10/2011	US20110274719 Helicobacter system and uses thereof
11/10/2011	US20110274718 System for Modulating Expression of Hypothalmic Brain-Derived Neurotrophic Factor (BDNF)

1 ... 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 ... 2211